Maya Lakshmi Harris (born January 30, 1967) is an American lawyer, public policy advocate, and writer. Harris was one of three senior policy advisors for Hillary Clinton's 2016 presidential campaign's policy agenda and she also served as chair of the 2020 presidential campaign of her sister, Kamala Harris.
Apr 28, 2021 · The latest tweets from @mayaharris_
Maya Harris was born as Maya Harris on January 30th 1967 in Champaign-Urbana, Illinois, United States to Shyamala Gopalan(Mother)- a civil rights activist and a cancer researcher of Indian origin & Donald Harris (father)- Stanford University economics professor.
- New York, United States
- 150' (46.15 m)
Aug 13, 2020 · Maya Harris. Maya Harris was born on January 30, 1967, and from Champaign-Urbana, Illinois, U.S. She is an American lawyer, public policy advocate, and television commentator. Furthermore, she’s the best know as the sister of Kamala Harris.
- 53 years old as of 2020
- Maya Harris
- January 30, 1967
Jan 19, 2021 · Previously, Maya Harris was the executive director at the American Civil Liberties Union of Northern California and a vice president at the Ford Foundation, whose mission is "to reduce poverty and ...
- 2 min
- James Crowley
- Melissa Goldberg
- Kamala and Maya Harris have always been close friends and sisters. On January 30, 1967, Shyamala Gopalan Harris, a breast cancer researcher who left India to get her doctorate at U.C.
- Maya Harris is a well-known civil rights lawyer and public policy advocate. After graduating from Stanford Law School in 1992, Maya practiced corporate law, while also teaching law school classes on the side.
- She worked on Hillary Clinton’s 2016 presidential campaign. It turns out her Senator sister's 2020 campaign is not Maya's first rodeo. In April 2015, Hillary Clinton hired Maya as one of three senior policy advisors for her presidential campaign.
- In April, she announced she has lupus—after battling the condition privately for more than three decades. In March, President Donald Trump first touted hydryroxychloroquine as a potential treatment for COVID-19—despite serious pushback from the F.D.A.